Objectives: Peripartum cardiomyopathy (PPCM) is a pathology in which the heart is dilated, and symptoms of heart failure are present. It is a rare condition with a high mortality rate, predominantly in black patients. Its diagnosis and management are not standardized, so we propose to evaluate the association of risk factors and the pharmacological regimen of affected patients in a public health institution in the Dominican Republic.
Methods: An observational, retrospective, cross-sectional study was carried out with convenience sampling. Patients admitted to the Doña Renée Klang Viuda de Guzmán Women's Hospital with suspected PPCM during the last 5 years were included.
Results: A sample of 21 patients with a median age of 27 years was obtained. Seventy-five percent were black. 100% of the patients with occurrence of PPCM in the peripartum period who presented adverse events had infectious comorbidities and "other comorbidities". On the other hand, 75% presented cardiac and pulmonary comorbidities.
Conclusion: It is important to design tools to calculate the risk of developing PPCM as well as to standardize its diagnosis and treatment in resource-limited countries. This to improve the prognosis in patients with risk factors, such as being black, being older than 30 years and living in low/medium resource countries.
Keywords:
Cardiomyopathies; demographic indicators; peripartum period; treatment outcomes